all is not dead yet. With the assumption that the advisory...

all is not dead yet. With the assumption that the advisory commitee is trully independant, then it is now up to QRX experts Halladay and Co. to convince the commitee that Moxduo has the safety benefits needed to be approvced. The QRX briefing docs make a compelling argument that Moxduo has obvious safety advanatages and it would seem to be a slam dunk for approval. Unfortunately the ADA doesnt agree, so now is the time for Halladay and Co to earn there money and get this over the line.